Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Bausch + Lomb and Nicox resubmit US New Drug Application for novel glaucoma candidate latanoprostene bunod

February 27, 2017

View Press Release Corporate presentation Contact us
Previous